PASCA 3.0 - Central American Project for Sustaining and Championing the Human Rights Response to Human Immunodeficiency Virus (HIV)
Guatemala USAID-Guatemala City · Agency for International Development
At a glance
PASCA 3.0 - Central American Project for Sustaining and Championing the Human Rights Response to Human Immunodeficiency Virus (HIV) is a closed federal cooperative agreement opportunity from the Guatemala USAID-Guatemala City (Agency for International Development). The application deadline was September 21, 2017. Individual awards are listed as $10M, with about 1 award expected and $10M in total estimated funding. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing or matching is required. It is funded under Assistance Listing 98.001 (USAID Foreign Assistance for Programs Overseas).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Jul 24, 2017Posted
- Sep 21, 2017Application deadline
- Posted
- Jul 24, 2017
- Close date
- Sep 21, 2017
- Award floor
- $10,000,000
- Award ceiling
- $10,000,000
- Est. total funding
- $10,000,000
- Original deadline (extended)
- Sep 7, 2017
- Expected awards
- 1
- Cost sharing
- Required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
Who can apply
- Unrestricted (any entity type)
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The purpose of this Activity is to move Central American countries towards a technically and financially sustainable strategy, to contain the HIV epidemic and fulfill the 90’s goals. This Activity will be the cornerstone of USAID’s work at the regional level and at the national or above-site level in the five countries where the Regional HIV/AIDS Program has presence and develops specific country activities: El Salvador, Guatemala, Honduras, Nicaragua, and Panama as well as regionally (including Belize and Costa Rica) when interventions involve COMISCA and the RCM.
Full announcement & documents
The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.
- RFA-596-17-000003Full Announcement · RFA-596-17-000003 - PASCA 3.pdfPDF · 4.4 MB
- Final RFA-596-17-000003 - Amendment No. 1.Other Supporting Documents · Final RFA-596-17-000003 - Amendment No. 1.pdfPDF · 215 KB
- Amendment No.2Other Supporting Documents · Final RFA-596-17-000003 - Amend No.2.pdfPDF · 357 KB
- Amendment No. 3Other Supporting Documents · Final RFA-596-17-000003 - Amend No.3.pdfPDF · 228 KB
Assistance Listing
What is an ALN?Reported obligations under ALN 98.001
Historical data · not a predictionAgency contact (as published)
Quick answers
Who is eligible to apply for this opportunity?
The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.
How much funding is available through this opportunity?
Per the notice, individual awards are listed as $10m, total estimated program funding is $10,000,000 and the agency expects to make about 1 awards.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-596-17-000003), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Limited Competition: International epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Dec 3, 2025 (est.)
- Who can apply
- Public colleges & universities, 501(c)(3) nonprofits, Private colleges & universities and 1 more
Notice of Intent to Publish a Funding Opportunity Announcement for HIV Pediatric, Adolescent and Maternal Clinical Trials
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Mar 25, 2026 (est.)
- Who can apply
- State governments, County governments, Independent school districts and 8 more
Centers for AIDS Research (CFAR)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Aug 19, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Martin Delaney Collaboratories for HIV Cure Research
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Aug 19, 2026 (est.)
- Who can apply
- State governments, County governments, Independent school districts and 8 more
ORACLE 3C: Chronic Conditions, Coinfections, and Comorbidities in HIV
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Sep 25, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Strengthening Ghana Health Service laboratory services, diagnostic networks, and systems for a more effective, efficient, and sustainable response to HIV, TB, and other priority health threats
Centers for Disease Control-GHC- Award range
- Amount not specified
- Closes
- Oct 16, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more